Quick filters
20
Matches
- A portfolio built for trend lovers Globe and Mail | Wednesday October 10, 2012 6:13PM
- Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer's Disease Business Wire | Tuesday January 17, 2012 7:00AM
- Medivation Announces Participation in 13th Annual BIO CEO & Investor Conference PR Newswire | Monday February 7, 2011 8:00AM
- Medivation Announces Participation in 29th Annual J.P. Morgan Healthcare Conference PR Newswire | Monday January 3, 2011 8:00AM
- Medivation Completes Enrollment in Phase 3 'CONCERT' Trial of Dimebon Added to Donepezil in Patients With Alzheimer's Disease PR Newswire | Tuesday December 7, 2010 8:00AM
- Medivation and Astellas Complete Enrollment in Phase 3 Affirm Trial of MDV3100 in Advanced Prostate Cancer PR Newswire | Monday November 29, 2010 4:05PM
- Medivation Reports Third Quarter 2010 Financial Results and Provides Corporate Update PR Newswire | Friday November 5, 2010 4:01PM
- Medivation Announces Third Quarter 2010 Financial Results Teleconference and Webcast on November 5, 2010 PR Newswire | Friday October 29, 2010 8:00AM
- Medivation Announces Participation in the NewsMakers in the Biotech Industry Conference PR Newswire | Tuesday October 19, 2010 8:00AM
- Medivation and Astellas Announce Initiation of a Second Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer PR Newswire | Wednesday September 29, 2010 8:00AM
- Medivation Announces Participation in the UBS Global Life Sciences Conference PR Newswire | Tuesday September 14, 2010 8:00AM
- Medivation Reports Second Quarter 2010 Financial Results and Provides Corporate Update PR Newswire | Monday August 9, 2010 4:02PM
- Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010 PR Newswire | Monday August 2, 2010 8:00AM
- Strategos/wRatings Innovation Index Identifies the Most Innovative Pharmaceutical and Medical Device Companies Business Wire | Tuesday May 11, 2010 8:00AM
- Medivation Reports First Quarter 2010 Financial Results and Provides Corporate Update PR Newswire | Monday May 10, 2010 4:01PM
- Medivation Announces First Quarter 2010 Financial Results Teleconference and Webcast on May 10, 2010 PR Newswire | Monday May 3, 2010 8:00AM
- Murray, Frank & Sailer LLP Files Class Action Against Medivation, Inc. Business Wire | Monday April 19, 2010 7:39PM
- Medivation and Astellas Announce Publication in The Lancet of Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients PR Newswire | Wednesday April 14, 2010 6:31PM
- Finkelstein Thompson LLP Announces Investigation of Medivation, Inc. Business Wire | Friday April 9, 2010 2:29PM
- Bernstein Liebhard LLP Announces Submission Deadline for Investors of Medivation, Inc. Business Wire | Wednesday April 7, 2010 11:42AM
Live Discussion of MDVN on StockTwits